CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: febuxostat
Accession: CHEBI:31596
browse the term
Definition: A 1,3-thiazolemonocarboxylic acid that is 4-methyl-1,3-thiazole-5-carboxylic acid which is substituted by a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally-active, potent, and selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricaemia in patients with gout.
Synonyms: exact_synonym: 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
related_synonym: 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid; Adenuric; Donifoxate; Febuday; Feburic; Formula=C16H16N2O3S; Goturic; Goutex; InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20); InChIKey=BQSJTQLCZDPROO-UHFFFAOYSA-N; SMILES=C1(=CC(=C(C=C1)OCC(C)C)C#N)C2=NC(=C(S2)C(=O)O)C; TEI 6720; TMX-67; Uloric; Zurig; febuxostatum
alt_id: CHEBI:45943
xref: CAS:144060-53-7; DrugBank:DB04854; Drug_Central:1137; KEGG:D01206; LINCS:LSM-3064
xref_mesh: MESH:D000069465
xref: PDBeChem:TEI; PMID:25724536; PMID:30844048; PMID:30919894; PMID:31267805; PMID:31332638; PMID:31335677; PMID:31378626; PMID:31447893; PMID:31449565; PMID:31499267; PMID:31531831; PMID:31560952; Wikipedia:Febuxostat
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions
EXP
Febuxostat inhibits the reaction [Paraquat results in decreased secretion of AGER protein modified form]; Febuxostat inhibits the reaction [Paraquat results in increased expression of AGER mRNA]
CTD
PMID:30726711
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of BAX protein]
CTD
PMID:26036690
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]
CTD
PMID:26036690
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]
CTD
PMID:26036690
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
Febuxostat results in increased expression of CCL2 mRNA
CTD
PMID:26641773
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ctnnb1
catenin beta 1
multiple interactions
EXP
Febuxostat inhibits the reaction [Paraquat results in increased expression of CTNNB1 protein]
CTD
PMID:30726711
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Febuxostat results in increased expression of DUSP10 mRNA
CTD
PMID:35866629
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
Febuxostat results in increased expression of DUSP4 mRNA
CTD
PMID:35866629
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
Febuxostat results in increased expression of DUSP5 mRNA
CTD
PMID:35866629
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp8
dual specificity phosphatase 8
increases expression
ISO
Febuxostat results in increased expression of DUSP8 mRNA
CTD
PMID:35866629
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
ISO
Febuxostat results in increased expression of GADD45G mRNA
CTD
PMID:35866629
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Got2
glutamic-oxaloacetic transaminase 2
multiple interactions
ISO
Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 mRNA]; Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 protein]
CTD
PMID:29107957
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
EXP
Febuxostat inhibits the reaction [Estradiol results in increased expression of HIF1A mRNA]
CTD
PMID:32228192
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
multiple interactions
EXP
Febuxostat inhibits the reaction [Paraquat results in increased expression of HMGB1 mRNA]
CTD
PMID:30726711
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of IKBKB protein]
CTD
PMID:26036690
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il1rap
interleukin 1 receptor accessory protein
increases expression
ISO
Febuxostat results in increased expression of IL1RAP mRNA
CTD
PMID:35866629
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
G
Il6
interleukin 6
multiple interactions
EXP
Febuxostat inhibits the reaction [Estradiol results in increased expression of IL6 protein]
CTD
PMID:32228192
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
Febuxostat results in increased phosphorylation of MAPK8 protein
CTD
PMID:35866629
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mmp9
matrix metallopeptidase 9
multiple interactions
EXP
Febuxostat inhibits the reaction [Paraquat results in increased expression of MMP9 protein]
CTD
PMID:30726711
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mras
muscle RAS oncogene homolog
increases expression
ISO
Febuxostat results in increased expression of MRAS mRNA
CTD
PMID:35866629
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
G
Nppb
natriuretic peptide B
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of NPPB protein]
CTD
PMID:26036690
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
Febuxostat results in increased expression of NR4A1 mRNA
CTD
PMID:35866629
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
Febuxostat inhibits the reaction [Paraquat results in increased expression of PTGS2 mRNA]
CTD
PMID:30726711
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of RELA protein]
CTD
PMID:26036690
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sod2
superoxide dismutase 2
multiple interactions
EXP
Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]
CTD
PMID:26036690
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP ISO
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of TNF protein] Febuxostat results in increased expression of TNF mRNA
CTD
PMID:26036690 PMID:26641773
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
Febuxostat inhibits the reaction [Estradiol results in increased expression of VEGFA protein]; Febuxostat inhibits the reaction [Paraquat results in increased expression of VEGFA protein]
CTD
PMID:30726711 PMID:32228192
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
decreases activity
ISO
Febuxostat results in decreased activity of XDH protein
CTD
PMID:35866629
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all